Snowball logo
logo
ACHI

Achiko AG

Fr0.007Fr0.00  (0%)
Estimate
EPS
-0.04
Beta
-0.703
About the company
Ticker
ACHI
ISIN
CH0522213468
Country
Switzerland
Sector (GICS)
Healthcare
Achiko AG engages in developing disruptive diagnostic solutions in Indonesia and internationally. The company's lead product is AptameX, a rapid test that uses DNA aptamers instead of antigens to detect the SARS-CoV-2 virus. It also offers Teman Sehat, a mobile check-in and passport application. In addition, the company provides secure payment solutions for game publishers and application developers to accept various payment methods for digital contents and goods under the Mimopay brand, as well as develops game software. Achiko AG was incorporated in 2018 and is headquartered in Zurich, Switzerland.

Frequently asked questions

What sector does Achiko AG (ACHI) operate in?

Achiko AG belongs to the Healthcare sector and operates in the Health Information Services industry.

What is Achiko AG (ACHI) current stock price?

As of the latest data, Achiko AG stock price is CHF 0.01, with a previous close of CHF 0.01.

What is Achiko AG (ACHI) current market capitalization?

Achiko AG market cap is approximately 1.02 million.

What is Achiko AG (ACHI) Earnings Per Share (EPS)?

The trailing EPS is -CHF 0.04.

Does Achiko AG (ACHI) pay dividends?

No. Achiko AG does not pay a dividend.

What is Achiko AG (ACHI) beta (volatility) score?

Achiko AG has a beta of -0.703, indicating lower volatility than the overall market.